Side-by-side comparison of AI visibility scores, market position, and capabilities
Dental marketing agency providing websites, SEO, PPC, and patient communication for dental practices in the US and Canada. Beaverton OR; founded 2009;
WEO Media is a Beaverton, Oregon-based dental-specific marketing agency and technology company that provides website design, search engine optimization, pay-per-click advertising, online reputation management, and patient communication tools to dental practices across the United States and Canada. Founded in 2009, WEO Media built its business around the unique marketing needs of independent dental practices and DSO-affiliated offices, which differ significantly from general small business marketing in their emphasis on local search visibility, treatment-specific landing pages, patient reviews, and HIPAA-compliant communication. The company combines managed digital marketing services with proprietary technology tools for patient communication and review generation, offering dental practices a full-service growth marketing partner.\n\nWEO Media's website platform is purpose-built for dental practices, with built-in features for treatment page templates, appointment request forms, before-and-after gallery management, and ADA accessibility compliance. The company's SEO methodology focuses on local search dominance—ensuring that each dental practice ranks prominently for high-intent searches like "dentist near me," "dental implants [city]," and "emergency dentist [neighborhood]"—which drives the majority of new patient acquisition for most dental offices. WEO Media manages Google Business Profiles, local citation building, and online review acquisition campaigns as integrated components of its local SEO service.\n\nWEO Media targets independent dental practices and small group practices that want to outsource their digital marketing to a specialist with deep dental industry knowledge rather than working with a general digital marketing agency that lacks familiarity with dental treatment marketing, HIPAA compliance requirements, and the competitive dynamics of local dental markets. The company competes with ProSites, TNT Dental, and PatientSites in the dental marketing agency space, as well as with in-house marketing capabilities at larger DSOs. WEO Media differentiates on its combination of managed services and proprietary technology and its long track record in the dental market.
Indianapolis global pharma (NYSE: LLY) at $45B 2024 revenue (+32%); first healthcare company to $1T market cap (Nov 2024) with Mounjaro/Zepbound tirzepatide (37% revenue) and oral GLP-1 orforglipron Phase 3 competing with Novo Nordisk.
Eli Lilly and Company is an Indianapolis, Indiana-based global pharmaceutical company — publicly traded on the New York Stock Exchange (NYSE: LLY) as an S&P 500 Dow Jones Industrial Average component — that in November 2024 became the world's most valuable pharmaceutical company with a historic $1 trillion market capitalization, the first healthcare company ever to reach this milestone. In fiscal year 2024, Lilly achieved approximately $45 billion in revenue, representing 32% growth from 2023, driven by blockbuster GLP-1 medications tirzepatide (Mounjaro for type 2 diabetes and Zepbound for obesity and obstructive sleep apnea), which together accounted for 37% of 2024 revenues. Other key products include Trulicity (dulaglutide, 12% of revenue), Humalog (insulin lispro, 5%), and Kisunla (donanemab), the first new Alzheimer's therapy approved for early symptomatic disease in 2024. An oral GLP-1 pill (orforglipron) is in Phase 3 clinical trials. CEO David Ricks has led the company since 2017. Founded in 1876 by Colonel Eli Lilly in Indianapolis, the company pioneered mass production of Jonas Salk's polio vaccine in 1955 and was among the first to produce human insulin using recombinant DNA technology.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.